CHC LABS INC.
SERUM IRON STUDIES
|
(82728,83540,83550,84466) |
|
|
002.0-002.9 |
Typhoid fever |
|
003.0-003.9 |
Salmonella gastroenteritis |
|
006.0-006.9 |
Acute amebic dysentery without abscess |
|
007.0-007.9 |
Balantidiasis |
|
008.00-008.8 |
Intestinal infection due to E. Coli unspecified |
|
009.0-009.3 |
Infectious colitis enteritis and gastroenteritis |
|
011.50-011.56 |
Tuberculous bronchiectasis unspecified examination |
|
014.00-014.86 |
Tuberculous peritonitis unspecified examination |
|
015.00-015.96 |
Tuberculosis of vertebral column unspecified examination |
|
016.00-016.06 |
Tuberculosis of kidney unspecified examination |
|
016.10-016.16 |
Tuberculosis of bladder unspecified examination |
|
016.20-016.26 |
Tuberculosis of ureter unspecified examination |
|
016.30-016.36 |
Tuberculosis of other urinary organs unspecified examination |
|
042 |
Human immunodeficiency virus (HIV) disease |
|
070.0-070.9 |
Viral Hepatitis A with hepatic coma |
|
140.0-149.9 |
Malignant neoplasm of upper lip vermilion border |
|
150.0-159.9 |
Malignant neoplasm of cervical esophagus |
|
160.0-165.9 |
Malignant neoplasm of nasal cavities |
|
170.0-176.9 |
Malignant neoplasm of bones of skull and face except mandible |
|
179-189.9 |
Malignant neoplasm of uterus, part unspecified |
|
190.0-199.1 |
Malignant neoplasm of eyeball, except conjunctiva, cornea, retina, and choroid |
|
200.00-208.91 |
Reticulosarcoma unspecified site |
|
210.0-229.9 |
Benign neoplasm of lip |
|
230.0-234.9 |
Carcinoma in situ of lip, oral cavity, and pharynx |
|
235.0-238.9 |
Neoplasm of uncertain behavior of major salivary gland |
|
239.0-239.9 |
Neoplasm of unspecified nature of digestive system |
|
250.00-250.93 |
Diabetes mellitus without complication type II or unspecified type not stated as uncontrolled |
|
253.2 |
Panhypopituitarism |
|
253.7 |
Iatrogenic pituitary disorders |
|
253.8 |
Other disorders of the pituitary and other syndromes of diencephalohypophyseal origin |
|
256.31-256.39 |
Premature menopause |
|
257.2 |
Other testicular hypofunction |
|
260 |
Kwashiorkor |
|
261 |
Nutritional marasmus |
|
262 |
Other severe protein-calorie malnutrition |
|
263.0-263.9 |
Malnutrition of moderate degree |
|
275.0 |
Disorders of iron metabolism |
|
277.1 |
Disorders of porphyrin metabolism |
|
280.0-280.9 |
Iron deficiency anemia secondary to blood loss (chronic) |
|
281.0-281.9 |
Pernicious anemia |
|
282.4 |
Thalassemias |
|
285.0 |
Sideroblastic anemia |
|
285.1 |
Acute posthemorrhagic anemia |
|
285.9 |
Anemia unspecified |
|
286.0-286.9 |
Congenital factor VIII disorder |
|
287.0-287.2 |
Allergic purpura |
|
287.30-287.39 |
Primary thrombocytopenia |
|
306.4 |
Gastrointestinal malfunction arising from mental factors |
|
307.1 |
Anorexia nervosa |
|
307.50-307.59 |
Eating disorder unspecified |
|
403.01 |
Hypertensive renal disease, malignant, with renal failure |
|
403.11 |
Hypertensive renal disease, benign, with renal failure |
|
403.91 |
Hypertensive renal disease, unspecified, with renal failure |
|
404.02 |
Hypertensive heart and renal disease, malignant, with renal failure |
|
404.03 |
Hypertensive heart and renal disease, malignant, with heart and renal failure |
|
404.12 |
Hypertensive heart and renal disease, benign, with renal failure |
|
404.13 |
Hypertensive heart and renal disease, benign, with heart and renal failure |
|
404.92 |
Hypertensive heart and renal disease, unspecified, with renal failure |
|
404.93 |
Hypertensive heart and renal disease, unspecified, with heart and renal failure |
|
425.4 |
Other primary cardiomyopathies |
|
425.5 |
Alcoholic cardiomyopathy |
|
425.7 |
Nutritional and metabolic cardiomyopathy |
|
425.8 Cardiomyopathy in other diseases classified elsewhere |
|
|
425.9 |
Secondary cardiomyopathy unspecified |
|
426.0-426.9 |
Atrioventricular block complete |
|
427.0-427.9 |
Paroxysmal supraventricular tachycardia |
|
428.0-428.9 |
Congestive heart failure unspecified |
|
530.7 |
Gastroesophageal laceration-hemorrhage syndrome |
|
530.82 |
Esophageal hemorrhage |
|
531.00-531.91 |
Acute gastric ulcer with hemorrhage without obstruction |
|
532.00-532.91 |
Acute duodenal ulcer with hemorrhage without obstruction |
|
533.00-533.91 |
Acute peptic ulcer of unspecified site with hemorrhage without obstruction |
|
534.00-534.91 |
Acute gastrojejunal ulcer with hemorrhage without obstruction |
|
535.00-535.61 |
Acute gastritis (without hemorrhage) |
|
536.0-536.9 |
Achlorhydria |
|
537.83 |
Angiodysplasia of stomach and duodenum with hemorrhage |
|
537.84 |
Dieulafoy lesion (hemorrhagic) of stomach and duodenum |
|
555.0-555.9 |
Regional enteritis of small intestine |
|
556.0-556.9 |
Ulcerative (chronic) enterocolitis |
|
557.0 |
Acute vascular insufficiency of intestine |
|
557.1 |
Chronic vascular insufficiency of intestine |
|
562.02 |
Diverticulosis of small intestine with hemorrhage |
|
562.03 |
Diverticulitis of small intestine with hemorrhage |
|
562.12 |
Diverticulosis of colon with hemorrhage |
|
562.13 |
Diverticulitis of colon with hemorrhage |
|
569.3 |
Hemorrhage of rectum and anus |
|
569.85 |
Angiodysplasia of intestine with hemorrhage |
|
569.86 |
Dieulafoy lesion (hemorrhagic) of intestine |
|
570 |
Acute and subacute necrosis of liver |
|
571.0-571.9 |
Alcoholic fatty liver |
|
572.0-572.8 |
Abscess of liver |
|
573.0-573.9 |
Chronic passive congestion of liver |
|
578.0-578.9 |
Hematemesis |
|
579.0-579.3 |
Celiac disease |
|
579.8-579.9 |
Other specified intestinal malabsorption |
|
581.0-581.9 |
Nephrotic syndrome with lesion of proliferative glomerulonephritis |
|
585.4 |
Chronic kidney disease, Stage IV (severe) |
|
585.5 |
Chronic kidney disease, Stave V |
|
585.6 |
End stage renal disease |
|
585.9 |
Chronic kidney disease, unspecified |
|
586 |
Renal failure unspecified |
|
608.3 |
Atrophy of testis |
|
626.0-626.9 |
Absence of menstruation |
|
627.0 |
Premenopausal menorrhagia |
|
627.1 |
Postmenopausal bleeding |
|
648.20-648.24 |
Anemia of mother complicating pregnancy, childbirth, or the puerperium unspecified as to episode of care |
|
698.0-698.9 |
Pruritus ani |
|
704.00-704.09 |
Alopecia unspecified |
|
709.00-709.09 |
Dyschromia unspecified |
|
713.0 |
Arthropathy associated with other endocrine and metabolic disorders |
|
716.40-716.99 |
Transient arthropathy site unspecified |
|
719.40-719.49 |
Pain in joint site unspecified |
|
773.2 |
Hemolytic disease of fetus or newborn due to other and unspecified isoimmunization |
|
773.3 |
Hydrops fetalis due to isoimmunization |
|
773.4 |
Kernicterus of fetus or newborn due to isoimmunization |
|
773.5 |
Late anemia of fetus or newborn due to isoimmunzation |
|
783.9 |
Other symptoms concerning nutrition metabolism and development |
|
790.01 |
Precipitous drop in hematocrit |
|
790.09 |
Other abnormality of red blood cells |
|
790.4 |
Nonspecific elevation of levels of transaminase or lactic acid dehydrogenase (LDH) |
|
790.5 |
Other nonspecific abnormal serum enzyme levels |
|
790.6 |
Other abnormal blood chemistry |
|
799.4 |
Cachexia |
|
964.0 |
Poisoning by iron and its compounds |
|
984.0-984.9 |
Toxic effect of inorganic lead compounds |
|
996.85 |
Complications of transplanted bone marrow |
|
999.8 |
Other transfusion reaction not elsewhere classified |
|
V08 |
Asymptomatic human immunodeficiency virus (HIV) infection status |
|
V12.1 |
Personal history of nutritional deficiency |
|
V12.3 |
Personal history of diseases of blood and blood-forming organs |
|
V15.1 |
Personal history of surgery to heart and great vessels presenting hazards to health |
|
V15.2 |
Personal history of surgery to other major organs presenting hazards to health |
|
V43.2 |
Heart replaced by other means |
|
V43.3 |
Heart valve replaced by other means |
|
V43.4 |
Blood vessel replaced by other means |
|
V43.60 |
Unspecified joint replacement |
|
V56.0 |
Aftercare involving extracorporeal dialysis |
|
V56.8 |
Aftercare involving other dialysis |
This policy has been duplicated from the most current Medicare National Coverage Determination or Local Medical Review Policy available at the time this booklet was printed in October 2005. Medicare will consider this test(s) medically reasonable and necessary only if the test(s) was performed for any of the diagnoses/conditions listed on this page. This information is subject to change without notice, and Covenant Health Care Labs (CHC) is not responsible for consequences that may result from using such information. CHC is not indicating one code is more acceptable than another, and that selected codes should reflect the patients actual medical condition as noted in their medical record.
|